Abstract
Purpose
To compare diagnostic yield and utility of a novel core biopsy needle (NCBN) with shortened tip dead space for percutaneous musculoskeletal biopsies with an established core biopsy needle (ECBN).
Methods
This study was IRB approved and HIPAA compliant. All percutaneous biopsies using an NCBN performed between July 2020 and August 2021 were retrospectively reviewed. Data on patient demographics, biopsy technique, biopsy needle, and histopathology were collated.
Results
Thirty-six patients were included in this study, 16 (44%) undergoing biopsy with both an NCBN and an ECBN, and 20 (56%) with an NCBN only. All 36 NCBN biopsies were 16 gauge. Fifteen (94%) of the ECBN biopsies were 14 gauge, and 1 (6%) was 16 gauge. Thirty-four (94%) of the NCBN and 15 (94%) of the ECBN biopsies were diagnostic. No adverse events were identified.
Conclusion
Both the NCBN and ECBN have high diagnostic rates. No adverse events were identified. NCBN could be considered for biopsy of lesions limited by anatomic location or near adjacent critical structures.
Similar content being viewed by others
References
Fraser-Hill MA, Renfrew DL. Percutaneous needle biopsy of musculoskeletal lesions. 1. Effective accuracy and diagnostic utility. AJR Am J Roentgenol. 1992;158:809–12.
Fraser-Hill MA, Renfrew DL, Hilsenrath PE. Percutaneous needle biopsy of musculoskeletal lesions. 2. Cost-effectiveness. AJR Am J Roentgenol. 1992;158:813–8.
Wu JS, Goldsmith JD, Horwich PJ, Shetty SK, Hochman MG. Bone and soft-tissue lesions: what factors affect diagnostic yield of image-guided core-needle biopsy? Radiology. 2008;248:962–70.
Kilpatrick SE, Cappellari JO, Bos GD, Gold SH, Ward WG. Is fine-needle aspiration biopsy a practical alternative to open biopsy for the primary diagnosis of sarcoma? Experience with 140 patients. Am J Clin Pathol. 2001;115:59–68.
Li NP, Wingfield MA, Mills MK, Beckett BR, Hansford BG. Percutaneous image-guided sternal biopsy: a cross-institutional retrospective review of diagnostic yield and safety in 50 cases. Skeletal Radiol. 2021;50:495–504.
Li Y, Du Y, Luo TY, Yang HF, Yu JH, Xu XX, et al. Factors influencing diagnostic yield of CT-guided percutaneous core needle biopsy for bone lesions. Clin Radiol. 2014;69:e43-47.
Husseini JS, Simeone FJ, Nelson SB, Chang CY. CT-guided discitis-osteomyelitis biopsies: needle gauge and microbiology results. Skeletal Radiol. 2020;49:1431–9.
Chang CY, Huang AJ, Bredella MA, Torriani M, Halpern EF, Rosenthal DI, et al. Percutaneous CT-guided needle biopsies of musculoskeletal tumors: a 5-year analysis of non-diagnostic biopsies. Skeletal Radiol. 2015;44:1795–803.
Chang I-YJ, Ilaslan H, Sundaram M, Schils J, Subhas N. CT-guided percutaneous biopsy of sclerotic bone lesions: diagnostic outcomes. Skeletal Radiol. 2018;47:661–9.
De Filippo M, Saba L, Rossi E, Nizzoli R, Tiseo M, Pedrazzi G, et al. Curved needles in CT-guided fine needle biopsies of abdominal and retroperitoneal small lesions. Cardiovasc Intervent Radiol. 2015;38:1611–6.
Cazzato RL, Garnon J, Shaygi B, Caudrelier J, Bauones S, Tsoumakidou G, et al. Performance of a new blunt-tip coaxial needle for percutaneous biopsy and drainage of “hard-to-reach” targets. Cardiovasc Intervent Radiol. 2017;40:1431–9.
AprioCore® plus - US ONLY [Internet]. AprioMed. [cited 2022 May 16]. Available from: https://apriomed.com/products/apriocore-plus-us-only/
Khalilzadeh O, Baerlocher MO, Shyn PB, Connolly BL, Devane AM, Morris CS, et al. Proposal of a new adverse event classification by the Society of Interventional Radiology Standards of Practice Committee. J Vasc Interv Radiol. 2017;28:1432-1437.e3.
TEMNO Evolution® Biopsy Device [Internet]. Merit Medical. [cited 2022 May 19]. Available from: https://www.merit.com/peripheral-intervention/biopsy/soft-tissue-biopsy/temno-evolution-biopsy-device/
Pritzker KPH, Nieminen HJ. Needle biopsy adequacy in the era of precision medicine and value-based health care. Arch Pathol Lab Med. 2019;143:1399–415.
Crenn V, Vezole L, Bouhamama A, Meurgey A, Karanian M, Marec-Bérard P, et al. Percutaneous core needle biopsy can efficiently and safely diagnose most primary bone tumors. Diagnostics (Basel). 2021;11:1552.
Le HBQ, Lee ST, Munk PL. Image-guided musculoskeletal biopsies. Semin Intervent Radiol. 2010;27:191–8.
Filippiadis DK, Charalampopoulos G, Mazioti A, Keramida K, Kelekis A. Bone and soft-tissue biopsies: what you need to know. Semin Intervent Radiol. 2018;35:215–20.
Didolkar MM, Anderson ME, Hochman MG, Rissmiller JG, Goldsmith JD, Gebhardt MG, et al. Image guided core needle biopsy of musculoskeletal lesions: are nondiagnostic results clinically useful? Clin Orthop Relat Res. 2013;471:3601–9.
Rimondi E, Rossi G, Bartalena T, Ciminari R, Alberghini M, Ruggieri P, et al. Percutaneous CT-guided biopsy of the musculoskeletal system: results of 2027 cases. Eur J Radiol. 2011;77:34–42.
Abboud S, Kosaraju V, Bhatt A, Egler R, Elliott R, Faraji N, et al. Multidisciplinary approach for repeat musculoskeletal lesion biopsy after nondiagnostic initial sampling: a 10-year single-center experience. J Surg Oncol. 2021;123:342–51.
Ramkumar DB, Kelly SP, Ramkumar N, Gyftopoulos S, Raskin KA, Lozano-Calderon SA, et al. Adjunct diagnostic strategies in improving diagnostic yields in image-guided biopsies of musculoskeletal neoplasms—a cost-effectiveness analysis. J Surg Oncol. 2021;124:1499–507.
MissionTM Disposable Core Biopsy Instrument [Internet]. [cited 2022 May 16]. Available from: https://www.bd.com/en-us/products-and-solutions/products/product-families/mission-disposable-core-biopsy-instrument
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethics approval
All procedures performed in studies involving human subjects were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This study was approved by the Partners Human Research IRB.
Consent to participate
The study was approved by the local Institutional Review Board (IRB) and HIPAA compliant. The study was considered exempt from consent because of the retrospective study design.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Cahalane, A.M., Habib, U., Balza, R. et al. A novel core biopsy needle with shorter dead space for percutaneous image-guided musculoskeletal biopsies — how does it compare with an established core biopsy needle?. Skeletal Radiol 52, 99–109 (2023). https://doi.org/10.1007/s00256-022-04130-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00256-022-04130-5